InAADR

Drug Information

Drug Name: clenbuterol (37148-27-9)
PubChem ID: 2783
SMILES: CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O
InchiKey: STJMRWALKKWQGH-UHFFFAOYSA-N
Therapeutic Category: Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-Agonists, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Respiratory System Agents, Sympathomimetics

Computed Drug Properties

Molecular Weight (dalton): 277.195
LogP: 2.9971
Ring Count: 1
Hydrogen Bond Acceptor Count: 3
Hydrogen Bond Donor Count: 3
Total Polar Surface Area: 58.28

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abnormal Behaviour MetaADEDB
Abnormal Movements MetaADEDB
Activated Partial Thromboplastin Time Prolonged MetaADEDB
Acute Brain Syndrome MetaADEDB
Acute Generalised Exanthematous Pustulosis MetaADEDB
Adynamic Ileus MetaADEDB
Agranulocytoses MetaADEDB
Alanine Aminotransferase Increased MetaADEDB
Allergic Dermatitis MetaADEDB
Altered State Of Consciousness MetaADEDB
Anaesthesia MetaADEDB
Anaphylactic Reaction MetaADEDB
Angiitis MetaADEDB
Anorexia MetaADEDB
Anosmia MetaADEDB
Anticholinergic Syndrome MetaADEDB
Arterial Pressure Nos Decreased MetaADEDB
Arteriospasm Coronary MetaADEDB
Aspartate Aminotransferase Increase MetaADEDB
Asthma MetaADEDB
Asthmatic Crisis MetaADEDB
Azotaemia MetaADEDB
Biliary Fibrosis MetaADEDB
Bladder Retention MetaADEDB
Blepharoptosis MetaADEDB
Blood Alkaline Phosphatase Increased MetaADEDB
Blood Bilirubin Increased MetaADEDB
Blood Glucose Decreased MetaADEDB
Blood Lactate Dehydrogenase Increased MetaADEDB
Blood Potassium Increased MetaADEDB
Blood Uric Acid MetaADEDB
Body Temperature Increased MetaADEDB
Cancer Pain MetaADEDB
Carcinoid Syndrome MetaADEDB
Chemotherapeutic Drug Level Increased MetaADEDB
Colitis Pseudomembranous MetaADEDB
Dermatitis Exfoliative MetaADEDB
Dermatitis Medicamentosa MetaADEDB
Dermographism MetaADEDB
Disease Recurrence MetaADEDB
Dyslalia MetaADEDB
Electrocardiogram St Segment Elevation MetaADEDB
Elevated Prostate Specific Antigen MetaADEDB
Empyema MetaADEDB
Encephalopathy MetaADEDB
Eosinophil Count Increased MetaADEDB
Eruption MetaADEDB
Erythropenia MetaADEDB
Eye Injury MetaADEDB
Faecal Incontinence MetaADEDB
Gamma-Glutamyltransferase Increased MetaADEDB
Head Injury MetaADEDB
Hepatic Function Abnormal MetaADEDB
Hepatic Neoplasm Malignant MetaADEDB
Hypoaesthesia Oral MetaADEDB
Lacunar Infarction MetaADEDB
Leukocyte Alkaline Phosphatase Increased MetaADEDB
Leukopenia Neonatal MetaADEDB
Light Sensitivity MetaADEDB
Liver Failure MetaADEDB
Lyell MetaADEDB
Muscular Atrophy MetaADEDB
Myocardial Infarction MetaADEDB
Myocardial Reperfusion Injury MetaADEDB
Pharmaceutical Product Complaint MetaADEDB
Pharyngeal Haemorrhage MetaADEDB
Platelet Count MetaADEDB
Prescribed Overdose MetaADEDB
Pulmonary Arrest MetaADEDB
Pulmonary Infarction MetaADEDB
Pustular Psoriasis MetaADEDB
Status Epilepticus MetaADEDB
Subcorneal Pustular Dermatosis MetaADEDB
Sudden Death MetaADEDB
Tremor MetaADEDB
Ventricular Fibrillation MetaADEDB
Wheeze MetaADEDB

InAADR: Drug-Protein-ADRs database